TransMedics, Inc.- Product Pipeline Analysis 2016 TransMedics, Inc.- Product Pipeline Analysis 2016

TransMedics, Inc.- Product Pipeline Analysis 2016 Industry Analysis and Forecast by Radiant Insights, Inc Summary TransMedics, Inc. (TransMedics) is a medical device company that develops organ transplant systems. The company offers product organ care systems that is used by surgeons in heart transplants and is a warm blood perfusion system which maintains organs in a warm functioning state outside of the body during transport from organ donor to recipient. TransMedics' product is also used for lung, liver and kidney transplants. Its organ care system functions are blood oxygenation, pulsative flow, physiological monitoring and warming. The company enables surgeons to transplant more organs from the available donor pool. It sells its products through a network of distributors in the US and abroad. TransMedics is headquartered in Andover, Massachusetts, the US. This report is a source for data, analysis, and actionable intelligence on the company's portfolio of pipeline products. The report provides key information about the company, its major products and brands. The report enhances decision making capabilities and help to create effective counter strategies to gain competitive advantage. Read Complete Report with TOC @ http://www.radiantinsights.com/research/transmedics-incproduct-pipeline-analysis-2016-update Scope: - The report reviews detailed company profile with information on business description, key company facts, major products and services, key competitors, key employees, locations and subsidiaries and recent developments - The report analyzes all pipeline products in development for the company TransMedics, Inc. - The report provides pipeline analysis on all pipeline products of the company (by equipment type, by indication, by development stage, and by trial status) - The report covers detailed information on each pipeline product with information on pipeline territory, stage of development, device class, regulatory path, indication(s), application(s) and estimated launch date - The report provides detailed description of products in development, technical specification and functions - The report also covers ongoing clinical trials (wherever applicable) with information on trial name, trial objective, sponsor, trial design , trial status and phase, estimated start and end date.